Study Compares 3 Common Prostate Cancer Treatments

TUESDAY, Jan. 31 (HealthDay News) -- Experts comparing three leading prostate cancer therapies find external beam radiation therapy to be more toxic and expensive than either surgery or a more localized form of radiation therapy known as brachytherapy.

Molecular Insight Pharmaceuticals, Inc. Presents Human Data Demonstrating Detection of Metastatic Prostate Cancer

CAMBRIDGE, MA-- - Molecular Insight Pharmaceuticals, Inc. will present first human data on the molecular imaging of metastatic prostate cancer in bone and soft tissue with their new 99mTc-radiolabeled ...

NAPT Responds to UNC Study Questioning Proton Therapy's Treatment of Prostate Cancer

Abstract is unremarkable and missing definitive data to make an informed decision.Washington, D.C. (PRWEB) February 01, 2012 In response to a study conducted at the University of North Carolina/Chapel Hill, as reported by the Associated Press, that questions the effectiveness of proton beam radiation therapy for the treatment of prostate cancer, the National Association for Proton Therapy (NAPT ...

Experimental Drugs Do Battle Against Advanced Prostate Cancer

TUESDAY, Jan. 31 (HealthDay News) -- Two new drugs, taken alone or potentially together, may boost survival for men with advanced prostate cancer, studies suggest.

Baldness: Treatment Options and Possible Link to Prostate Cancer

Interest in this unlikely duo arose recently when the U.S. Preventive Services Task Force (USPSTF) discouraged using prostate specific antigen (PSA) as a screen for prostate cancer in men with no symptoms of the disease.